Search

Search Constraints

You searched for: Author/Creator Colpani, M.

Search Results

1. Early changes in non invasive assessment of liver fibrosis in hepatitis C virus-infected patients treated with DAAs: Preliminary reports. Issue 1 (16th February 2017)

2. Early changes in non-invasive assessment of liver fibrosis in hepatitis C virus-infected patients treated with DAAs: Preliminary reports. (8th October 2016)

3. Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients. (February 2019)

4. Genotype 3 infection in DAA era: Reports of a real life Northern Italy Network for viral hepatitis after 2 years by the start. Issue 1 (16th February 2017)

5. Influence of DAA treatment on waitlisting and transplant rate for HCV related disease: Preliminary results of a single center experience. Issue 1 (February 2018)

6. Long‐term outcomes of direct acting antivirals in post‐transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis. Issue 10 (5th May 2017)

8. Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy. (February 2019)